News and Trends 30 Sep 2016
Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment
GeNeuro is developing a unique treatment for multiple sclerosis. We interviewed Miguel Payro, the company's CFO, who explained its advantageous position against big pharma. GeNeuro raised €33M in its Euronext IPO in April and is…
